Efavirenz increases the
plasma levels of ethinylestradiol.
Despite this increase, the manufacturers recommend using a reliable method of barrier contraception as they cannot rule out the potential for contraceptive failure. Note that this is also advisable to reduce the risk of HIV
transmission.